Department of Quality Assurance Technique, Sanjivani College of Pharmaceutical Education and Research, At Sahajandnagar, Post- Shinganapur, Tal, Kopargaon, Dist-Ahmednagar, Maharashtra, 423603, India.
Antiinflamm Antiallergy Agents Med Chem. 2023;22(4):220-229. doi: 10.2174/0118715230259623231111165759.
By comparing the histamine impact to the instant response to an injected foreign protein in previously sensitized animals, one might hypothesize that histamine may be involved in this reaction. Through all four of the recognized types of histamine receptors, histamine is also essential for the control of immunological function and acute and chronic allergic inflammation.
Recent evidence points to anti-IgE antibodies and specific antibodies to cytokines like IL-4 or IL-5 that are associated with allergic inflammation as probable causes of Allergic Rhinitis. The therapeutic advantage of antihistamines is a decrease in allergy symptoms and any other allergy-related symptoms. We research the many diseases and dose forms in which antihistamines are used. Pediatric age groups have never been thoroughly studied for firstgeneration antihistamines. Oral antihistamines are suggested as the first line of therapy for people with mild to severe intermittent Allergic Rhinitis symptoms.
Currently, approximately 100 different antihistamine-containing medicines and around 20 different H1-receptor antagonists are available for therapeutic use. Antihistamines of the second generation are more efficient and secure than those of the first generation. We conducted a research on the sedative and non-sedative effects of antihistamines used to treat various diseases.
The present investigation highlights the use of antihistamines in various diseases at different ages, their sedative and non-sedative effect, and their utility in treating insomnia based on their safety and current use among the patient population, as well as our observation.
通过比较组胺对先前致敏动物中注射的外来蛋白质的即刻反应的影响,可以假设组胺可能参与这种反应。通过所有四种公认的组胺受体类型,组胺对于控制免疫功能和急性和慢性过敏炎症也是必不可少的。
最近的证据表明,抗 IgE 抗体和特定的细胞因子(如 IL-4 或 IL-5)抗体与过敏炎症有关,可能是过敏性鼻炎的原因。抗组胺药的治疗优势在于减少过敏症状和任何其他与过敏相关的症状。我们研究了抗组胺药用于多种疾病和剂型。第一代抗组胺药从未在儿科年龄组中进行过彻底研究。口服抗组胺药被推荐为轻度至重度间歇性过敏性鼻炎症状患者的一线治疗药物。
目前,大约有 100 种含有抗组胺药的药物和 20 种不同的 H1 受体拮抗剂可用于治疗。第二代抗组胺药比第一代更有效和安全。我们研究了用于治疗各种疾病的抗组胺药的镇静和非镇静作用。
本研究强调了在不同年龄、不同疾病中使用抗组胺药的情况,根据其安全性和当前在患者群体中的使用情况,以及我们的观察,评估了其镇静和非镇静效果,以及在治疗失眠症方面的应用。